Tag: NIH
-
Biotech Gains Antibody Discovery, Manufacturing Funds
A Canadian biotechnology company is receiving government funds for Covid-19 antibody discovery and manufacturing for current and future pandemics.
-
NIH Opens Covid-19 Diagnostic Test Challenge
National Institutes of Health began a competition for new diagnostic tests that can better determine the extent of Covid-19 infections in the U.S.
-
BARDA Chief Removed for “Politics and Cronyism”
The director of the federal agency protecting against pandemics says he was removed for refusing to endorse President Trump’s preferred Covid-19 treatment.
-
Moderna Gains $483M for Covid-19 Vaccine
A government preparedness agency awarded biotechnology company Moderna Inc. $483 million to advance its Covid-19 vaccine through clinical trials.
-
Five Covid-19 Vaccines in Clinical Trials
A review of vaccines for preventing Covid-19 infections shows five of those projects are in early-stage clinical trials, with 18 more in preclinical stage.
-
Trial to Test Electronic-Aided Covid-19 Vaccine
A company developing cancer immunotherapies is adapting its electronic-assisted process to create a vaccine protecting against Covid-19 infections.
-
WHO Beginning Covid-19 Therapy Trial
World Health Organization is organizing an international clinical trial to test four treatments for the novel coronavirus, or Covid-19, pandemic.
-
FDA Outlines Trial Disruption Steps Due to Covid-19
The Food and Drug Administration outlined steps clinical trial teams should take if their studies face disruptions from the novel coronavirus, or Covid-19, pandemic.
-
Lilly, Biotech, NIH to Develop Covid-19 Antibodies
Drug maker Eli Lilly and Co., a biotechnology company, and an agency of NIH are collaborating on antibodies for novel coronavirus vaccines and therapies.
-
FDA Clears High-Volume Covid-19 Test
The Food and Drug Administration cleared for use in the U.S. a high-volume diagnostic for the novel coronavirus that can run on automated systems already in place.